Miss Gloria Cimaglia
Teams and roles for Gloria Cimaglia
Publication
2025
- Durmaz, E., Esmaeli, M., Lewis, P., Cimaglia, G., Clayton, A. and Mead, B. 2025. R-28 cell-derived extracellular vesicles protect retinal ganglion cells in glaucoma. Neural Regeneration Research 10, article number: 4103. (10.4103/NRR.NRR-D-24-00709)
2024
- Morgan, J. E., Bevan, R. J. and Cimaglia, G. 2024. Retinal ganglion cell subtypes and their vulnerability in glaucoma. In: Jacobs, T. and Liton, P. B. eds. Glaucoma. Methods and Protocols., Vol. 2858. Methods in Molecular Biology New York, NY, USA:, pp. 191-205., (10.1007/978-1-0716-4140-8_16)
- Bevan, R. J., Cimaglia, G., Morgan, J. E. and Taylor, P. R. 2024. Improved DiOlistic labelling technique for neurons in situ: Detailed visualisation of dendritic spines and concurrent histochemical-detection in fixed tissue. Methods 229, pp. 82-93. (10.1016/j.ymeth.2024.06.009)
- Cimaglia, G., Tribble, J. R., Votruba, M., Williams, P. A. and Morgan, J. E. 2024. Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma. Acta Neuropathologica Communications 12, article number: 137. (10.1186/s40478-024-01850-8)
- Kim, M. et al. 2024. Extracellular vesicle encapsulated nicotinamide delivered via a trans-scleral route provides retinal ganglion cell neuroprotection. Acta Neuropathologica Communications 12(1), article number: 65. (10.1186/s40478-024-01777-0)
2023
- Cimaglia, G., Bevan, R. J., Want, A. and Morgan, J. E. 2023. Gene gun DiOlistic labelling of retinal ganglion cells. In: Mead, B. ed. Retinal Ganglion Cells: Methods and Protocols., Vol. 2708. New York, NY: Springer, pp. n/a., (10.1007/978-1-0716-3409-7_4)
- Cimaglia, G. 2023. Targeting NAD+ for retinal ganglion cell protection in experimental glaucoma. PhD Thesis, Cardiff University.
2021
2020
Adrannau llyfrau
- Morgan, J. E., Bevan, R. J. and Cimaglia, G. 2024. Retinal ganglion cell subtypes and their vulnerability in glaucoma. In: Jacobs, T. and Liton, P. B. eds. Glaucoma. Methods and Protocols., Vol. 2858. Methods in Molecular Biology New York, NY, USA:, pp. 191-205., (10.1007/978-1-0716-4140-8_16)
- Cimaglia, G., Bevan, R. J., Want, A. and Morgan, J. E. 2023. Gene gun DiOlistic labelling of retinal ganglion cells. In: Mead, B. ed. Retinal Ganglion Cells: Methods and Protocols., Vol. 2708. New York, NY: Springer, pp. n/a., (10.1007/978-1-0716-3409-7_4)
Erthyglau
- Durmaz, E., Esmaeli, M., Lewis, P., Cimaglia, G., Clayton, A. and Mead, B. 2025. R-28 cell-derived extracellular vesicles protect retinal ganglion cells in glaucoma. Neural Regeneration Research 10, article number: 4103. (10.4103/NRR.NRR-D-24-00709)
- Bevan, R. J., Cimaglia, G., Morgan, J. E. and Taylor, P. R. 2024. Improved DiOlistic labelling technique for neurons in situ: Detailed visualisation of dendritic spines and concurrent histochemical-detection in fixed tissue. Methods 229, pp. 82-93. (10.1016/j.ymeth.2024.06.009)
- Cimaglia, G., Tribble, J. R., Votruba, M., Williams, P. A. and Morgan, J. E. 2024. Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma. Acta Neuropathologica Communications 12, article number: 137. (10.1186/s40478-024-01850-8)
- Kim, M. et al. 2024. Extracellular vesicle encapsulated nicotinamide delivered via a trans-scleral route provides retinal ganglion cell neuroprotection. Acta Neuropathologica Communications 12(1), article number: 65. (10.1186/s40478-024-01777-0)
- Tribble, J. R. et al. 2021. Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction. Redox Biology 43, article number: 101988. (10.1016/j.redox.2021.101988)
- Cimaglia, G., Votruba, M., Morgan, J. E., André, H. and Williams, P. A. 2020. Potential therapeutic benefit of NAD+ supplementation for glaucoma and age-related macular degeneration. Nutrients 12(9), article number: 2871. (10.3390/nu12092871)
Gosodiad